Top Telehealth Companies in Houston, TX (5)
ReviveRX is a leading licensed mail-order pharmacy specializing in generic and compounded medications. Our compounds are expertly crafted in USP-certified clean rooms at our Houston headquarters, ensuring the highest quality standards. We work closely with best-in-class pharmacists, scientists, healthcare providers, and pharmaceutical manufacturers to provide high-quality, dependable products to our patients and clinic partners.
Cantex Continuing Care Network provides a comprehensive continuum of care, including skilled nursing, rehabilitation, home health, hospice, and pharmacy services, focused on promoting recovery and enhancing patient quality of life.
Connect Pediatrics specializes in providing in-home pediatric nursing and therapy services for infants and children across Texas, Oklahoma, and Colorado. The company focuses on fostering relationships with caregivers and families to deliver high-quality health care tailored to each patient's needs.
Luna is a leading in-home, tech-enabled physical therapy platform that provides 1:1 personalized care. By shifting treatment from the clinic to the home, the company improves accessibility, convenience, and patient outcomes. Luna leverages proprietary technology like Auto-Charting® to streamline documentation for therapists, allowing them to focus on patient care. The company partners with major health systems and is covered by...
United Surgical Partners International (USPI), a subsidiary of Tenet Healthcare Corporation (NYSE: THC), operates the largest ambulatory platform in the country. With more than 465+ facilities across the United States, the company serves patients in ambulatory surgery centers and surgical hospitals. For more information, please visit www.uspi.com. USPI’s mission is simple, but the gravity of it is profound. We care for...
United Surgical Partners International's Top Stability & Growth Strengths
Strong Market Position & Advantage: Evidence indicates USPI leads the ambulatory surgery center sector by footprint and market standing, consistently referenced as the largest national platform. Industry and company descriptions highlight broad scale, procedure volume, and leadership within a consolidating yet fragmented market.
Strong Revenue Growth: Descriptions point to steady year-over-year increases in ambulatory segment revenue and earnings through 2024–2025, with raised outlooks signaling sustained momentum. Same-facility growth and higher revenue per case underscore a durable top-line trajectory.
Market Expansion: Evidence shows rapid network growth via acquisitions and de novo centers across many states and specialties. Partnerships and joint ventures with physician groups and health systems further extend geographic reach and service breadth.
